Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for Orofacial Neuropathic Pain
NCT00852436Phase 2Terminated
- Sponsor
- University of Toronto
- Start
- Feb 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pregabalin in neuropathic orofacial pain (NOP), sponsored by University of Toronto. Started Feb 2009; status: terminated.
02
Drugs
pregabalin
03
Conditions
neuropathic orofacial pain (NOP)
Beyond the preview
Go deeper on NCT00852436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00852436.